BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27874956)

  • 21. Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma.
    Gao KT; Lian D
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3561-5. PubMed ID: 27649655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
    Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
    Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
    Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
    Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
    Zhang SZ; Cai L; Li B
    Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
    Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
    Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic value and mechanism of long non-coding RNA DLEU1 in osteosarcoma].
    Zhang JJ; Yang P; Shang XQ
    Zhongguo Gu Shang; 2023 Jun; 36(6):559-64. PubMed ID: 37366099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.
    Sun B; Yang M; Li M; Wang F
    Biomed Pharmacother; 2015 Apr; 71():58-63. PubMed ID: 25960216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA SNHG6 promotes osteosarcoma cell proliferation through regulating p21 and KLF2.
    Ruan J; Zheng L; Hu N; Guan G; Chen J; Zhou X; Li M
    Arch Biochem Biophys; 2018 May; 646():128-136. PubMed ID: 29608878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.
    Yin Z; Ding H; He E; Chen J; Li M
    Oncol Rep; 2016 Oct; 36(4):2033-40. PubMed ID: 27513470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA BCAR4 promotes liver cancer progression by regulating proliferation, migration and invasion.
    Wang A; Meng J; Liu H; Li C; Zhou Z
    Oncol Lett; 2020 Sep; 20(3):2779-2787. PubMed ID: 32782595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of long non-coding RNA EWSAT1 as a novel prognostic biomarker in osteosarcoma.
    Zhang GY; Zhang JF; Hu XM; Luo ZP; Ma YZ
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5337-5341. PubMed ID: 29243774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic significance of S100A4 expression in osteosarcoma.
    Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
    Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes.
    Yang Y; Fei M; Zhou X; Li Y; Jin D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1859-1866. PubMed ID: 31397185
    [No Abstract]   [Full Text] [Related]  

  • 36. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GAPLINC is a predictor of poor prognosis and regulates cell migration and invasion in osteosarcoma.
    Liao S; Zhou S; Wang C
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30177521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
    Liu F; Xing L; Zhang X; Zhang X
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells.
    Ruan W; Wang P; Feng S; Xue Y; Li Y
    Tumour Biol; 2016 Mar; 37(3):4065-73. PubMed ID: 26486328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.